Nymox Pharmaceutical Corp - ESG Rating & Company Profile powered by AI
Jump to the end of the webpage for potential risks for Nymox Pharmaceutical Corp based on sector, geography and size. The dashboard contains a questions and answers table on Nymox Pharmaceutical Corp. The assessment of Nymox Pharmaceutical Corp was assembled by All Street Sevva using advanced Cognitive Robots.
Nymox Pharmaceutical Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 0.0, social score of 1.6 and governance score of 2.0.
1.2
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
1755 | Trimurthi Ltd | 1.3 | Low |
1779 | Nymox Pharmaceutical Corp | 1.2 | Low |
1779 | Cell Biotech Co Ltd | 1.2 | Low |
1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Nymox Pharmaceutical Corp have an accelerator or VC vehicle to help deliver innovation?
Does Nymox Pharmaceutical Corp disclose current and historical energy intensity?
Does Nymox Pharmaceutical Corp report the average age of the workforce?
Does Nymox Pharmaceutical Corp reference operational or capital allocation in relation to climate change?
Does Nymox Pharmaceutical Corp disclose its ethnicity pay gap?
Does Nymox Pharmaceutical Corp disclose cybersecurity risks?
Does Nymox Pharmaceutical Corp offer flexible work?
Does Nymox Pharmaceutical Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Nymox Pharmaceutical Corp disclose the number of employees in R&D functions?
Does Nymox Pharmaceutical Corp conduct supply chain audits?
Does Nymox Pharmaceutical Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Nymox Pharmaceutical Corp conduct 360 degree staff reviews?
Does Nymox Pharmaceutical Corp disclose the individual responsible for D&I?
Does Nymox Pharmaceutical Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Nymox Pharmaceutical Corp disclose current and / or historical scope 2 emissions?
Does Nymox Pharmaceutical Corp disclose water use targets?
Does Nymox Pharmaceutical Corp have careers partnerships with academic institutions?
Did Nymox Pharmaceutical Corp have a product recall in the last two years?
Does Nymox Pharmaceutical Corp disclose incidents of discrimination?
Does Nymox Pharmaceutical Corp allow for Work Councils/Collective Agreements to be formed?
Has Nymox Pharmaceutical Corp issued a profit warning in the past 24 months?
Does Nymox Pharmaceutical Corp disclose parental leave metrics?
Does Nymox Pharmaceutical Corp disclose climate scenario or pathway analysis?
Does Nymox Pharmaceutical Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Nymox Pharmaceutical Corp disclose the pay ratio of women to men?
Does Nymox Pharmaceutical Corp support suppliers with sustainability related research and development?
Does Nymox Pharmaceutical Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Nymox Pharmaceutical Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Nymox Pharmaceutical Corp involved in embryonic stem cell research?
Does Nymox Pharmaceutical Corp disclose GHG and Air Emissions intensity?
Does Nymox Pharmaceutical Corp disclose its waste policy?
Does Nymox Pharmaceutical Corp report according to TCFD requirements?
Does Nymox Pharmaceutical Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Nymox Pharmaceutical Corp disclose energy use targets?
Does Nymox Pharmaceutical Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Nymox Pharmaceutical Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Nymox Pharmaceutical Corp
These potential risks are based on the size, segment and geographies of the company.
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.